한글목차

대퇴골관 브러쉬 시장은 2023년에 3억 5,010만 달러에 달했고, 2024-2033년간 3.3%의 연평균 복합 성장률(CAGR)로 성장하여 2033년에는 4억 8,490만 달러에 달할 것으로 예상됩니다.

대퇴골관 브러쉬는 정형외과 수술, 특히 인공관절 치환술에 사용되는 특수 수술 기구입니다. 이 브러쉬는 대퇴골(허벅지 뼈)의 공동인 대퇴관을 청소하고 준비하여 느슨한 뼈 파편, 지방 및 기타 연조직 잔여물을 제거하도록 설계되었습니다. 이러한 준비는 보철 구성 요소의 적절한 접합 및 고정을 보장하여 장기적인 안정성을 촉진하고 임플란트 풀림과 같은 합병증의 위험을 줄입니다.

세계 대퇴골관 브러쉬 시장은 골관절염, 류마티스 관절염, 외상성 관절 손상과 같은 관절 질환의 유병률 증가와 전 세계 정형외과 수술 건수 증가 등의 요인으로 인해 강력한 성장을 목격하고 있습니다. 세계보건기구(WHO)가 발표한 2022년 조사에 따르면, 2019년 전 세계 약 5억 2,800만 명이 골관절염을 앓고 있는 것으로 나타났습니다. 이는 대퇴골관 브러쉬와 같은 수술 도구의 긴급한 필요성을 강조하고 있습니다. 또한, 노인 인구의 급격한 증가는 세계 시장의 주요 원동력으로 작용합니다. 이는 전 세계 고령화 인구가 급증하면서 고관절 및 무릎 인공관절 치환술에 대한 수요가 증가하고 있기 때문입니다. 세계보건기구(WHO)가 발표한 2024년 조사에 따르면, 2020년 10억 명의 노인 인구가 2030년까지 14억 명으로 늘어날 것으로 예상하고 있습니다. 또한, 80세 이상 고령자 수는 2050년까지 4억 2,600만 명에 달할 것으로 추정됩니다. 또한, 인도, 브라질, 중국 등 신흥 경제국의 의료 인프라가 빠르게 발전하면서 정형외과 수술에 대한 접근성이 높아져 대퇴골관 브러쉬 시장의 성장을 뒷받침하고 있습니다. 수술 후 감염은 정형외과 수술에서 심각한 문제로 남아 있습니다. 대퇴골관 브러쉬는 수술 부위를 청결하게 유지하여 감염 위험을 줄이는 데 중요한 역할을 하고 있으며, 이로 인해 수요가 더욱 증가하고 있습니다. 그러나 대퇴골관 브러쉬와 기타 수술 도구의 높은 가격은 특히 신흥 시장이나 의료 예산이 제한된 지역에서는 장벽이 될 수 있습니다. 또한, 대퇴골관 브러쉬가 필요하지 않은 비침습적 또는 최소침습적 수술 증가는 수요에 영향을 미칠 수 있기 때문에 시장 성장을 저해할 수 있습니다. 반면, 생체적합성 및 내구성이 뛰어난 강모와 같은 재료 및 디자인 혁신으로 인해 대퇴골관 브러쉬의 효율성이 향상되고 있습니다. 이는 정형외과 수술에서의 채택을 촉진하여 예측 기간 동안 세계 시장 확대에 유익한 기회를 제공할 것으로 예상됩니다.

대퇴골관 브러쉬 세계 시장 규모는 용도, 용도, 최종 사용자, 지역별로 구분됩니다. 용도에 따라 시장은 세척과 탈부착으로 나뉩니다. 용도별로는 뼈 시멘트, 인공고관절, 인공관절, 기타로 분류됩니다. 최종 사용자에 따라 병원, 외래수술센터(ASC) 및 기타로 나뉩니다. 지역별로는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 분석됩니다.

주요 조사 결과

용도별로는 세정 분야가 2024년부터 2033년까지 시장을 독점할 것으로 예상됩니다.

용도별로는 골 시멘트 분야가 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다.

최종 사용자별로는 병원 부문이 향후 몇 년동안 대퇴골관 브러쉬 시장을 주도할 것으로 예상됩니다.

지역별로는 북미가 예측 기간 동안 대퇴골관 브러쉬의 가장 유리한 시장으로 부상할 가능성이 높습니다.

본 보고서의 커스터마이징이 가능합니다.(추가 비용과 일정이 있습니다.)

• 규제 가이드라인
• 고객의 관심사에 따른 기업 프로파일 추가
• 국가별 또는 지역별 추가 분석 - 시장 규모 및 전망
• 기업 프로파일 확장 목록
• 과거 시장 데이터
• 주요 기업 세부 정보(위치, 연락처, 공급업체/벤더 네트워크 등 포함, 엑셀 형식)

목차

제1장 서론

제2장 주요 요약

제3장 시장 구도

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter의 Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회

제4장 대퇴골관 브러쉬 시장 : 용법별

• 시장 개요
• Cleaning
• Debride

제5장 대퇴골관 브러쉬 시장 : 용도별

• 시장 개요
• 골시멘트
• 고관절 치환술
• 관절 치환술
• 기타

제6장 대퇴골관 브러쉬 시장 : 최종사용자별

• 시장 개요
• 병원
• 외래수술센터(ASC)
• 기타

제7장 대퇴골관 브러쉬 시장 : 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국 대퇴골관 브러쉬 시장
  • 캐나다 대퇴골관 브러쉬 시장
  • 멕시코 대퇴골관 브러쉬 시장
• 유럽
  • 주요 시장 동향과 기회
  • 독일 대퇴골관 브러쉬 시장
  • 프랑스 대퇴골관 브러쉬 시장
  • 영국 대퇴골관 브러쉬 시장
  • 이탈리아 대퇴골관 브러쉬 시장
  • 스페인 대퇴골관 브러쉬 시장
  • 기타 유럽 대퇴골관 브러쉬 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 일본 대퇴골관 브러쉬 시장
  • 중국 대퇴골관 브러쉬 시장
  • 인도 대퇴골관 브러쉬 시장
  • 호주 대퇴골관 브러쉬 시장
  • 한국 대퇴골관 브러쉬 시장
  • 기타 아시아태평양 대퇴골관 브러쉬 시장
• 라틴아메리카, 중동 및 아프리카
  • 주요 시장 동향과 기회
  • 브라질 대퇴골관 브러쉬 시장
  • 사우디아라비아 대퇴골관 브러쉬 시장
  • 남아프리카공화국 대퇴골관 브러쉬 시장
  • 기타 라틴아메리카, 중동 및 아프리카 대퇴골관 브러쉬 시장

제8장 경쟁 구도

• 서론
• 주요 성공 전략
• 주요 10개 기업의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝, 2023년

제9장 기업 개요

• Stryker Corporation
• B. Braun SE
• Becton, Dickinson And Company
• Advanced Medical Systems Limited
• McKesson Medical-Surgical Inc.
• Judd Medical Limited
• Zimmer Biomet
• Smith And Nephew
• Tecres S.p.A.
• Edwards Lifesciences Corporation

영문목차

The femoral canal brush market was valued at $350.1 million in 2023, and is projected to reach $484.9 million by 2033, growing at a CAGR of 3.3% from 2024 to 2033.

A femoral canal brush is a specialized surgical tool used in orthopedic procedures, particularly during joint replacement surgeries. It is designed to clean and prepare the femoral canal-the hollow space within the femur (thigh bone)-by removing loose bone debris, fat, and other soft tissue residues. This preparation ensures proper cementing and fixation of the prosthetic components, promoting long-term stability and reducing the risk of complications like implant loosening.

The global femoral canal brush market is witnessing robust growth due to factors such as alarming rise in prevalence of joint disorders such as osteoarthritis, rheumatoid arthritis, and trauma-related joint injuries and increase in number of orthopedic surgeries worldwide. As per a 2022 study published by the World Health Organization, approximately 528 million individuals worldwide were suffering from osteoarthritis in 2019. This highlights the urgent need for surgical tools like femoral canal brushes. In addition, surge in geriatric population acts as a key driving force of the global market. This is attributed to the fact that with the global aging population growing rapidly, the demand for hip and knee replacements is on the rise. A 2024 study published by the World Health Organization revealed that the number of aged individuals will increase from 1 billion in 2020 to 1.4 billion by 2030. Moreover, the number of individuals aging 80 years and older is estimated to reach 426 million by 2050. Furthermore, rapid development of healthcare infrastructure in emerging economies, such as India, Brazil, and China, has increased access to orthopedic surgeries, supporting the growth of the femoral canal brush market. Post-operative infections remain a critical concern in orthopedic procedures. Femoral canal brushes play a key role in reducing the risk of infections by ensuring a clean surgical site, thereby further driving their demand. However, high cost of femoral canal brushes and other surgical instruments can be a barrier, particularly in emerging markets and regions with limited healthcare budgets. In addition, rise of non-invasive or minimally invasive surgical procedures, which might not require femoral canal brushes, could impact their demand, thus hampering the market growth. On the contrary, innovations in materials and design, such as biocompatible and durable bristles, have enhanced the efficiency of femoral canal brushes. This has driven their adoption in orthopedic procedures, which is expected to offer remunerative opportunities for the expansion of the global market during the forecast period.

The global femoral canal brush market size is segmented into usage, application, end user, and region. On the basis of the usage, the market is bifurcated into cleaning and debride. By application, it is classified into bone cement, hip replacement, joint replacement, and others. Depending on end user, it is divided into hospitals, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By usage, the cleaning segment is expected to dominate the market from 2024 to 2033.

On the basis of application, the bone cement segment is anticipated to exhibit the highest growth rate during the forecast period.

Depending on end user, the hospitals segment is projected to lead the femoral canal brush market in the upcoming years.

Region wise, North America is likely to emerge as the most lucrative market for femoral canal brushes throughout the forecast period.

Competition Analysis

The major players operating in the global femoral canal brush market include Stryker Corporation, B. Braun SE, Becton, Dickinson and Company , Advanced Medical Systems Limited, McKesson Medical-Surgical Inc., Judd Medical Limited , Zimmer Biomet, Smith & Nephew, Tecres S.p.A., and Edwards Lifesciences Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Usage

• Cleaning
• Debride

By Application

• Bone Cement
• Hip Replacement
• Joint Replacement
• Others

By End User

• Hospitals
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Stryker Corporation
• B. Braun SE
• Becton, Dickinson and Company
• Advanced Medical Systems Limited
• McKesson Medical-Surgical Inc.
• Judd Medical Limited
• Zimmer Biomet
• Smith & Nephew
• Tecres S.p.A.
• Edwards Lifesciences Corporation

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.4. Market Dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities

CHAPTER 4: FEMORAL CANAL BRUSH MARKET, BY USAGE

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Usage
• 4.2. Cleaning
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. Debride
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: FEMORAL CANAL BRUSH MARKET, BY APPLICATION

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By Application
• 5.2. Bone Cement
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Hip Replacement
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country
• 5.4. Joint Replacement
  • 5.4.1. Key Market Trends, Growth Factors and Opportunities
  • 5.4.2. Market Size and Forecast, By Region
  • 5.4.3. Market Share Analysis, By Country
• 5.5. Others
  • 5.5.1. Key Market Trends, Growth Factors and Opportunities
  • 5.5.2. Market Size and Forecast, By Region
  • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: FEMORAL CANAL BRUSH MARKET, BY END USER

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By End User
• 6.2. Hospitals
  • 6.2.1. Key Market Trends, Growth Factors and Opportunities
  • 6.2.2. Market Size and Forecast, By Region
  • 6.2.3. Market Share Analysis, By Country
• 6.3. Ambulatory Surgical Centers
  • 6.3.1. Key Market Trends, Growth Factors and Opportunities
  • 6.3.2. Market Size and Forecast, By Region
  • 6.3.3. Market Share Analysis, By Country
• 6.4. Others
  • 6.4.1. Key Market Trends, Growth Factors and Opportunities
  • 6.4.2. Market Size and Forecast, By Region
  • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: FEMORAL CANAL BRUSH MARKET, BY REGION

• 7.1. Market Overview
  • 7.1.1 Market Size and Forecast, By Region
• 7.2. North America
  • 7.2.1. Key Market Trends and Opportunities
  • 7.2.2. Market Size and Forecast, By Usage
  • 7.2.3. Market Size and Forecast, By Application
  • 7.2.4. Market Size and Forecast, By End User
  • 7.2.5. Market Size and Forecast, By Country
  • 7.2.6. U.S. Femoral Canal Brush Market
    • 7.2.6.1. Market Size and Forecast, By Usage
    • 7.2.6.2. Market Size and Forecast, By Application
    • 7.2.6.3. Market Size and Forecast, By End User
  • 7.2.7. Canada Femoral Canal Brush Market
    • 7.2.7.1. Market Size and Forecast, By Usage
    • 7.2.7.2. Market Size and Forecast, By Application
    • 7.2.7.3. Market Size and Forecast, By End User
  • 7.2.8. Mexico Femoral Canal Brush Market
    • 7.2.8.1. Market Size and Forecast, By Usage
    • 7.2.8.2. Market Size and Forecast, By Application
    • 7.2.8.3. Market Size and Forecast, By End User
• 7.3. Europe
  • 7.3.1. Key Market Trends and Opportunities
  • 7.3.2. Market Size and Forecast, By Usage
  • 7.3.3. Market Size and Forecast, By Application
  • 7.3.4. Market Size and Forecast, By End User
  • 7.3.5. Market Size and Forecast, By Country
  • 7.3.6. Germany Femoral Canal Brush Market
    • 7.3.6.1. Market Size and Forecast, By Usage
    • 7.3.6.2. Market Size and Forecast, By Application
    • 7.3.6.3. Market Size and Forecast, By End User
  • 7.3.7. France Femoral Canal Brush Market
    • 7.3.7.1. Market Size and Forecast, By Usage
    • 7.3.7.2. Market Size and Forecast, By Application
    • 7.3.7.3. Market Size and Forecast, By End User
  • 7.3.8. UK Femoral Canal Brush Market
    • 7.3.8.1. Market Size and Forecast, By Usage
    • 7.3.8.2. Market Size and Forecast, By Application
    • 7.3.8.3. Market Size and Forecast, By End User
  • 7.3.9. Italy Femoral Canal Brush Market
    • 7.3.9.1. Market Size and Forecast, By Usage
    • 7.3.9.2. Market Size and Forecast, By Application
    • 7.3.9.3. Market Size and Forecast, By End User
  • 7.3.10. Spain Femoral Canal Brush Market
    • 7.3.10.1. Market Size and Forecast, By Usage
    • 7.3.10.2. Market Size and Forecast, By Application
    • 7.3.10.3. Market Size and Forecast, By End User
  • 7.3.11. Rest Of Europe Femoral Canal Brush Market
    • 7.3.11.1. Market Size and Forecast, By Usage
    • 7.3.11.2. Market Size and Forecast, By Application
    • 7.3.11.3. Market Size and Forecast, By End User
• 7.4. Asia-Pacific
  • 7.4.1. Key Market Trends and Opportunities
  • 7.4.2. Market Size and Forecast, By Usage
  • 7.4.3. Market Size and Forecast, By Application
  • 7.4.4. Market Size and Forecast, By End User
  • 7.4.5. Market Size and Forecast, By Country
  • 7.4.6. Japan Femoral Canal Brush Market
    • 7.4.6.1. Market Size and Forecast, By Usage
    • 7.4.6.2. Market Size and Forecast, By Application
    • 7.4.6.3. Market Size and Forecast, By End User
  • 7.4.7. China Femoral Canal Brush Market
    • 7.4.7.1. Market Size and Forecast, By Usage
    • 7.4.7.2. Market Size and Forecast, By Application
    • 7.4.7.3. Market Size and Forecast, By End User
  • 7.4.8. India Femoral Canal Brush Market
    • 7.4.8.1. Market Size and Forecast, By Usage
    • 7.4.8.2. Market Size and Forecast, By Application
    • 7.4.8.3. Market Size and Forecast, By End User
  • 7.4.9. Australia Femoral Canal Brush Market
    • 7.4.9.1. Market Size and Forecast, By Usage
    • 7.4.9.2. Market Size and Forecast, By Application
    • 7.4.9.3. Market Size and Forecast, By End User
  • 7.4.10. South Korea Femoral Canal Brush Market
    • 7.4.10.1. Market Size and Forecast, By Usage
    • 7.4.10.2. Market Size and Forecast, By Application
    • 7.4.10.3. Market Size and Forecast, By End User
  • 7.4.11. Rest of Asia-Pacific Femoral Canal Brush Market
    • 7.4.11.1. Market Size and Forecast, By Usage
    • 7.4.11.2. Market Size and Forecast, By Application
    • 7.4.11.3. Market Size and Forecast, By End User
• 7.5. LAMEA
  • 7.5.1. Key Market Trends and Opportunities
  • 7.5.2. Market Size and Forecast, By Usage
  • 7.5.3. Market Size and Forecast, By Application
  • 7.5.4. Market Size and Forecast, By End User
  • 7.5.5. Market Size and Forecast, By Country
  • 7.5.6. Brazil Femoral Canal Brush Market
    • 7.5.6.1. Market Size and Forecast, By Usage
    • 7.5.6.2. Market Size and Forecast, By Application
    • 7.5.6.3. Market Size and Forecast, By End User
  • 7.5.7. Saudi Arabia Femoral Canal Brush Market
    • 7.5.7.1. Market Size and Forecast, By Usage
    • 7.5.7.2. Market Size and Forecast, By Application
    • 7.5.7.3. Market Size and Forecast, By End User
  • 7.5.8. South Africa Femoral Canal Brush Market
    • 7.5.8.1. Market Size and Forecast, By Usage
    • 7.5.8.2. Market Size and Forecast, By Application
    • 7.5.8.3. Market Size and Forecast, By End User
  • 7.5.9. Rest of LAMEA Femoral Canal Brush Market
    • 7.5.9.1. Market Size and Forecast, By Usage
    • 7.5.9.2. Market Size and Forecast, By Application
    • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top Winning Strategies
• 8.3. Product Mapping Of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

• 9.1. Stryker Corporation
  • 9.1.1. Company Overview
  • 9.1.2. Key Executives
  • 9.1.3. Company Snapshot
  • 9.1.4. Operating Business Segments
  • 9.1.5. Product Portfolio
  • 9.1.6. Business Performance
  • 9.1.7. Key Strategic Moves and Developments
• 9.2. B. Braun SE
  • 9.2.1. Company Overview
  • 9.2.2. Key Executives
  • 9.2.3. Company Snapshot
  • 9.2.4. Operating Business Segments
  • 9.2.5. Product Portfolio
  • 9.2.6. Business Performance
  • 9.2.7. Key Strategic Moves and Developments
• 9.3. Becton, Dickinson And Company
  • 9.3.1. Company Overview
  • 9.3.2. Key Executives
  • 9.3.3. Company Snapshot
  • 9.3.4. Operating Business Segments
  • 9.3.5. Product Portfolio
  • 9.3.6. Business Performance
  • 9.3.7. Key Strategic Moves and Developments
• 9.4. Advanced Medical Systems Limited
  • 9.4.1. Company Overview
  • 9.4.2. Key Executives
  • 9.4.3. Company Snapshot
  • 9.4.4. Operating Business Segments
  • 9.4.5. Product Portfolio
  • 9.4.6. Business Performance
  • 9.4.7. Key Strategic Moves and Developments
• 9.5. McKesson Medical-Surgical Inc.
  • 9.5.1. Company Overview
  • 9.5.2. Key Executives
  • 9.5.3. Company Snapshot
  • 9.5.4. Operating Business Segments
  • 9.5.5. Product Portfolio
  • 9.5.6. Business Performance
  • 9.5.7. Key Strategic Moves and Developments
• 9.6. Judd Medical Limited
  • 9.6.1. Company Overview
  • 9.6.2. Key Executives
  • 9.6.3. Company Snapshot
  • 9.6.4. Operating Business Segments
  • 9.6.5. Product Portfolio
  • 9.6.6. Business Performance
  • 9.6.7. Key Strategic Moves and Developments
• 9.7. Zimmer Biomet
  • 9.7.1. Company Overview
  • 9.7.2. Key Executives
  • 9.7.3. Company Snapshot
  • 9.7.4. Operating Business Segments
  • 9.7.5. Product Portfolio
  • 9.7.6. Business Performance
  • 9.7.7. Key Strategic Moves and Developments
• 9.8. Smith And Nephew
  • 9.8.1. Company Overview
  • 9.8.2. Key Executives
  • 9.8.3. Company Snapshot
  • 9.8.4. Operating Business Segments
  • 9.8.5. Product Portfolio
  • 9.8.6. Business Performance
  • 9.8.7. Key Strategic Moves and Developments
• 9.9. Tecres S.p.A.
  • 9.9.1. Company Overview
  • 9.9.2. Key Executives
  • 9.9.3. Company Snapshot
  • 9.9.4. Operating Business Segments
  • 9.9.5. Product Portfolio
  • 9.9.6. Business Performance
  • 9.9.7. Key Strategic Moves and Developments
• 9.10. Edwards Lifesciences Corporation
  • 9.10.1. Company Overview
  • 9.10.2. Key Executives
  • 9.10.3. Company Snapshot
  • 9.10.4. Operating Business Segments
  • 9.10.5. Product Portfolio
  • 9.10.6. Business Performance
  • 9.10.7. Key Strategic Moves and Developments